Exelixis
EXEL
#1458
Rank
A$21.22 B
Marketcap
A$85.67
Share price
1.42%
Change (1 day)
45.38%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Quarterly Reports

Thumbnail Exelixis Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report